| Family | Gene | UniprotID | PDB | Resolution | Activity | Spatial-Dihedral | Chelix-SaltBridge | ActLoopNT-ActLoopCT | APEtype | APEdihe | APEdist | Ligand | Ligand Type | Residues in structure | Unresolved residues in A-loop | Phosphorylation | Mutation | Protein |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CMGC | CDK2 | CDK2_HUMAN | 9ETPC | 2.48 | Active | DFGin‑BLAminus | in-in | in-in | nonTYR | APEdihe_aaiii | APEdist_iiii | BYZ, BYZ, BYZ | Type1, Allosteric, Allosteric | 1 - 296 | 0 | TPO160 | None | Cyclin-dependent kinase 2 |
| CMGC | CDK2 | CDK2_HUMAN | 9ETPA | 2.48 | Active | DFGin‑BLAminus | in-in | in-in | nonTYR | APEdihe_aaiii | APEdist_iiii | BYZ, BYZ, BYZ, BYZ, BYZ, BYZ | Type1, Allosteric, Allosteric, Allosteric, Allosteric, Allosteric | 1 - 297 | 0 | TPO160 | None | Cyclin-dependent kinase 2 |
| CMGC | CDK2 | CDK2_HUMAN | 6Q3CA | 1.29 | Inactive | None‑None | out-out | out-out | nonTYR | APEdihe_aaioi | APEdist_oooo | BYZ, BYZ | Type1, Type1 | 2 - 298 | 0 | None | None | Cyclin-dependent kinase 2 |
| TKL | ACVR1 | ACVR1_HUMAN | 5S7ZB | 1.3 | Inactive | DFGin‑BLAminus | in-out | in-out | nonTYR | APEdihe_aaiii | APEdist_iooi | LU8, BYZ | Type1, Allosteric | 205 - 499 | 0 | None | Q207D | Activin receptor type-1 |
| TKL | ACVR1 | ACVR1_HUMAN | 5S7ZA | 1.3 | Inactive | DFGin‑BLAminus | in-out | in-out | nonTYR | APEdihe_aaiii | APEdist_iooi | LU8, LU8, LU8, BYZ, BYZ | Type1, Allosteric, Allosteric, Allosteric, Allosteric | 202 - 499 | 0 | None | Q207D | Activin receptor type-1 |
| Family | Gene | UniprotID | PDB | Resolution | Activity | Spatial-Dihedral | Chelix-SaltBridge | ActLoopNT-ActLoopCT | APEtype | APEdihe | APEdist | Ligand | Ligand Type | Residues in structure | Unresolved residues in A-loop | Phosphorylation | Mutation | Protein | Organism |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CMGC | CDK2 | CDK2_HUMAN | 9ETPC | 2.48 | Active | DFGin‑BLAminus | in-in | in-in | nonTYR | APEdihe_aaiii | APEdist_iiii | BYZ, BYZ, BYZ | Type1, Allosteric, Allosteric | 1 - 296 | 0 | TPO160 | None | Cyclin-dependent kinase 2 | Homo sapiens |
| CMGC | CDK2 | CDK2_HUMAN | 9ETPA | 2.48 | Active | DFGin‑BLAminus | in-in | in-in | nonTYR | APEdihe_aaiii | APEdist_iiii | BYZ, BYZ, BYZ, BYZ, BYZ, BYZ | Type1, Allosteric, Allosteric, Allosteric, Allosteric, Allosteric | 1 - 297 | 0 | TPO160 | None | Cyclin-dependent kinase 2 | Homo sapiens |
| CMGC | CDK2 | CDK2_HUMAN | 6Q3CA | 1.29 | Inactive | None‑None | out-out | out-out | nonTYR | APEdihe_aaioi | APEdist_oooo | BYZ, BYZ | Type1, Type1 | 2 - 298 | 0 | None | None | Cyclin-dependent kinase 2 | Homo sapiens |
| TKL | ACVR1 | ACVR1_HUMAN | 5S7ZB | 1.3 | Inactive | DFGin‑BLAminus | in-out | in-out | nonTYR | APEdihe_aaiii | APEdist_iooi | LU8, BYZ | Type1, Allosteric | 205 - 499 | 0 | None | Q207D | Activin receptor type-1 | Homo sapiens |
| TKL | ACVR1 | ACVR1_HUMAN | 5S7ZA | 1.3 | Inactive | DFGin‑BLAminus | in-out | in-out | nonTYR | APEdihe_aaiii | APEdist_iooi | LU8, LU8, LU8, BYZ, BYZ | Type1, Allosteric, Allosteric, Allosteric, Allosteric | 202 - 499 | 0 | None | Q207D | Activin receptor type-1 | Homo sapiens |
| Spatial label | Dihedral label | Number of Chains | Percent | Representative |
|---|
| Family | Gene | UniprotID | PDB | Resolution | Activity | Spatial-Dihedral | Chelix-SaltBridge | ActLoopNT-ActLoopCT | APEtype | APEdihe | APEdist | Ligand | Ligand Type | Residues in structure | Unresolved residues in A-loop | Phosphorylation | Mutation | Protein | Organism |
|---|